Tuesday, October 8, 2002

ASTRO 2002

The Gold Medals Award Ceremony

70 Gy Thoracic Radiotherapy (TRT) is Feasible Concurrent with Chemotherapy for Limited Stage Small Cell Lung Cancer (L-SCLC): Preliminary Analysis of a CALGB Phase II Trial Presenter: J.A. BogartPresenter's Affiliation: Upstate Medical University, Syracuse, NY, USAType of Session: ScientificBackground This study was designed to further investigate the optimal treatment regimen for L-SCLC. A previous randomized...
Accelerated Partial Breast Irradiation Via Interstitial Brachytherapy as the Sole Radiation Modality for Treatment of Early-Stage Breast Cancer Presenter: Peter Y. ChenPresenter's Affiliation: Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MIType of Session: ScientificBackground In several randomized clinical trials BCT including whole breast irradiation has been...
ASTRO 2002 Gold Medal Awards The Gold Medal is the American Society of Therapeutic Radiology and Oncology's (ASTRO) highest honor, bestowed upon revered radiation oncologists, biologists,and physicists. The award is given in recognition of distinguished accomplishments and...
Brachytherapy Alone Versus Whole Breast Radiotherapy After Breast Conserving Surgery: 5-year Results of a Phase I-II Study and Interim Findings of a Phase III Trial Presenter: Csaba PolgarPresenter's Affiliation: Department of Radiotherapy, National Institute of Oncology, Budapest, HungaryType of Session: ScientificBackground Partial breast irradiation (PBI) has recently received alot of attention, especially...
Concurrent Chemo-Radiation Results in Equivalent Local and Overall Outcome as Induction Chemotherapy Followed by Surgery for Clinical Stage IIIA Non-Small Cell Lung Cancer Presenter: N.A. TaylorPresenter's Affiliation: Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX, USAType of Session: ScientificBackground In this study, investigators looked at 2 different treatment regimens for clinical...
Long-Term Complication Risk After Very High Dose Thoracic Radiotherapy Presenter: Mitchell AnscherPresenter's Affiliation: Duke UniversityType of Session: ScientificBackground Although significant gains have been made in the treatment of non-small cell lung cancer (NSCLC) with the use of chemoradiation, patients as a...
Phase III Trial of Amisfostine with Chemoradiation for Inoperable Non Small Cell Lung Cancer (NSCLC): Does Amifostine Protect Cancer Cells? Presenter: Ritusko KomakiPresenter's Affiliation: MD Anderson Cancer CenterType of Session: ScientificBackground Several randomized studies have proven improved outcomes with chemoradiation vs. radiation alone in the treatment of inoperable NSCLC. ...
Predictors of Survival for Patients With Brain Metastases: Results of a Randomized Phase III Trial Presenter: Walter CurranPresenter's Affiliation: Thomas Jefferson UniversityType of Session: ScientificBackground Brain metastases occur in 20-40% of all patients with cancer. There is a general life expectancy of these patients, though it may vary...
Radiotherapy (RT) Patterns of Care Study (PCS) in Lung Carcinoma Presenter: B. MovsasPresenter's Affiliation: Fox Chase Cancer Center (FCCC), Phila, PA, USAType of Session: ScientificBackground This study was designed to determine the national patterns of radiation therapy (RT) practice in patients treated for...
Randomized Prospective Comparison of Stereotactic Radiosurgery (SRS) Followed by Conventional Radiotherapy (RT) with BCNU to RT with BCNU Alone for Selected Patients with Supratentorial Glioblastoma Multiforme (GBM): Report of RTOG 93-05 Protocol. Presenter: L. SouhamiPresenter's Affiliation: McGill University, Montreal, QC, CanadaType of Session: ScientificBackground GBM continues to prove a most challenging tumor to treat. In spite of aggressive therapy local recurrence remains a significant...
Temozolomide Concomitant and Sequential to Radiotherapy as First Line of Treatment in Glioblastoma Multiforme: An Ongoing Multicentric Phase 2 Trial Presenter: L. FatigantePresenter's Affiliation: Department of Oncology, Radiotherapy, Pisa, ITType of Session: ScientificBackground Glioblastoma Multiforme (GBM) is associated with a high rate of local recurrence after primary therapy and a high...
Use of Complementary and Alternative Medicine in Radiotherapy Patients - Results of a German Multicenter Study Presenter: Micke, OliverPresenter's Affiliation: Department of Radiotherapy, Münster University Hospital, MünsterType of Session: ScientificBackground The use of complementary and alternative medicine (CAM) is a frequent phenomenon among cancer...
Whole Brain Radiotherapy Alone or in Combination with Temozolomide (TMZ) for Brain Metastases. A Phase III Study Presenter: D. AntonadouPresenter's Affiliation: Radiation Oncology Department, Metaxas Cancer Hospital, Pireus, GRType of Session: ScientificBackground Brain metastases are a common phenomenon in cancer patients and an increasingly important cause of...